On December 31, 2023, Glenview Capital Management, led by Larry Robbins (Trades, Portfolio), made a significant addition to its investment portfolio by acquiring 1,500,000 shares of Myriad Genetics Inc (NASDAQ:MYGN). The trade had a 0.65% impact on the portfolio, bringing the position to 2.29% of the portfolio and 5.97% of the company's shares.

Related Keywords

United States , Bracanalysis Cdx , Genetics Inc , While Fisher Asset Management , Myriad Genetics Inc , Myriad Genetics , Glenview Capital Management , Evaluation Metrics , Financial Strength , Profitability Rank , Growth Rank , Momentum Rank , Largest Guru , Fisher Asset Management , Larry Robbins , Barry Robbins , Investment Strategy , Grades , Investment Portfolio , Portfolio , Healthcare Sector , Global Payments Inc ,